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Objectives: We have developed an image-guided surgical system based on invisible near-infrared fluorescent
light. Presently, the only clinically available near-infrared fluorophore is indocyanine green, which fluoresces
at approximately 800 nm and is used for coronary angiography. Our objective was to determine whether meth-
ylene blue, already US Food and Drug Administration approved for other indications, has useful near-infrared
fluorescence properties for image-guided cardiac surgery.
Methods: The optical properties of methylene blue were measured after dissolution in 100% serum. Biodistri-
bution and clearance were quantified in organs and tissue after intravenous bolus injection of 2 mg/kg methylene
blue in 3 rats. Coronary arteriography and cardiac perfusion were imaged in real time after intravenous bolus in-
jection of 1 mg/kg methylene blue in 5 pigs with coronary obstructions. Coronary angiography and acute thrombi
were assessed by using 800-nm fluorophores, indocyanine green, and IR-786–labeled platelets, respectively.
Results: The peak absorbance and emission of methylene blue as a near-infrared fluorophore occur at 667 nm and
686 nm, respectively. After intravenous injection, methylene blue provides highly sensitive coronary angiogra-
phy. A lipophilic cation, methylene blue is extracted rapidly into tissue, with myocardium displaying unusually
high uptake. Methylene blue permits real-time visualization and quantitative assessment of myocardial perfusion.
Because of absent spectral overlap, use of 2 independent fluorophores in our imaging system permits simulta-
neous quantification of perfusion, venous drainage, and/or intravascular thrombi.
Conclusions: Methylene blue is an effective near-infrared fluorophore that provides direct visualization of cor-
onary arteriography and cardiac perfusion. In conjunction with approximately 800-nm near-infrared fluoro-
phores, important functional assessments during cardiac surgery are also possible.E
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SImmediate and long-term outcomes of coronary artery by-
pass grafting (CABG) are typically dependent on the quality
of the anastomosis, the conduit, and the distal myocardial
runoff. In current practice there is typically no standardized
approach for the intraoperative assessment of the anastomo-
sis or the distal runoff. Although postoperative aspirin ad-
ministration and increased use of arterial grafting have
improved early and late graft patency, perioperative graft
occlusions are still reported at a rate of between 4% and
12%.1,2 If such graft failures can be recognized intraopera-
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doi:10.1016/j.jtcvs.2008.09.082The Journal of Thoracic and Ctively, they might be correctable. Because graft patency and
completeness of revascularization are 2 important prognos-
tic factors for long-term survival after coronary surgery, a re-
liable and well-validated method to assess anastomoses and
perfusion would be helpful.
Near-infrared (NIR) fluorescent light (700–900 nm),
which is invisible to the human eye, provides an extremely
high signal/background ratio without changing the look of
the tissue being imaged.3 Our laboratory has previously
developed a 1-channel intraoperative NIR fluorescence
imaging system capable of visualizing otherwise invisible
relevant surgical anatomy by using a color video camera
and NIR fluorescence from an NIR camera.4 Using a variety
of large-animal model systems, we have shown that NIR
fluorescence can be used for effective image-guided sentinel
lymph node mapping,5 cardioplegia delivery,6 ureter identi-
fication,7 and extrahepatic bile duct identification.8 Our
group has also demonstrated that autologous washed plate-
lets can be rendered NIR fluorescent at 800 nm and, when
injected intravenously, will home to sites of intravascular
thrombi to provide high-sensitivity detection.9
There are presently 2 fundamental limitations to the wide-
spread clinical use of NIR fluorescence technology: the
availability of US Food and Drug Administration (FDA)–ardiovascular Surgery c Volume 138, Number 1 133
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CABG ¼ coronary artery bypass grafting
FBS ¼ fetal bovine serum
FDA ¼ US Food and Drug Administration
HEPES ¼ N-2-hydroxyethylpiperazine-N-2-
ethanesulfonic acid
ICG ¼ indocyanine green
LAD ¼ left anterior descending coronary artery
MB ¼ methylene blue
NIR ¼ near-infrared
QY ¼ quantum yield
approved NIR fluorophores and the availability of imaging
systems capable of visualizing more than 1 NIR fluorophore
simultaneously. Indocyanine green (ICG) is a small-mole-
cule blood pool agent that fluoresces at 800 nm and has pre-
viously been used for coronary angiography during CABG
surgery.10-12Methylene blue (MB) is another FDA-approved
fluorophore that heretofore has not been used for intraopera-
tive imaging. In this study we hypothesized that MB has
independent and nonoverlapping optical and pharmacoki-
netic properties compared with ICG and that it can therefore
be imaged concomitantly with ICG and other 800-nm fluoro-
phores to provide simultaneous and unique image guidance
during cardiac surgery.
MATERIALS AND METHODS
Dual-Channel NIR Fluorescence Imaging System
Our FLARE (Fluorescence-Assisted Resection and Exploration) large-
animal, single-channel intraoperative NIR fluorescence imaging system
has been described in detail previously.4,13 We recently developed a dual-
NIR version that includes a light-emitting diode–based light source that gen-
erates 1 mW/cm2 of 400- to 650-nm ‘‘white’’ light, 2.5 mW/cm2 of 670-nm
excitation light for NIR fluorescence channel 1, and 5 mW/cm2 of 760-nm
NIR excitation light for NIR fluorescence channel 2. Photon collection was
achieved with footswitch-controlled zoom optics that maintain separation of
the white light and 2 NIR fluorescence emission (700 and 800 nm, respec-
tively) channels. The system has a spatial resolution of 625 mm at a field of
view of 203 15 cm and 125 mm at a field of view of 43 3 cm. Color video
images were acquired on an IMI tech IMC-80F camera (IMI Tech, Seoul,
Korea). NIR fluorescence images were acquired on two 12-bit Orca-AG
cameras (Hamamatsu, Bridgewater, NJ) used within their linear range. After
computer-controlled camera acquisition, standard (white light) and 2 func-
tional (NIR fluorescent light) video images can be displayed separately and
merged. The imaging system was suspended over the surgical field with an
articulating arm, with a working distance of 18 inches above the subject.
Data were acquired and quantified on a Dell computer by using custom Lab-
VIEW 7.1 software (National Instruments, Austin, Tex).
NIR Fluorophore Preparation
Ten milligrams per milliliter (1%) sterile vials of MB in water and 25-mg
sterile vials of ICG (aka CardioGreen) powder were purchased from Akorn,
Inc (Decatur, Ill). The perchlorate salt of IR-786 (CAS #102185-03-5) was
purchased from Sigma–Aldrich (St Louis, Mo), and bioactive, autologous
NIR fluorescent pig platelets were prepared as described previously.9 Briefly,
platelet-rich plasma was isolated by means of centrifugation of 200 mL of134 The Journal of Thoracic and Cardiovascular Surwhole blood at 200g for 20 minutes. Platelets were isolated from platelet-
rich plasmabymeans of centrifugation at 1400g for 10minutes in the presence
of 50 ng/mL prostaglandin E1 and 10% (vol/vol) acid citrate/dextrose, pH 4.6,
and resuspended at a concentration of 4 3 108 platelets/mL in Tyrode’s–N-
2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES) buffer. The
washed platelets (3.6 3 1010 total) in Tyrode’s–HEPES buffer were labeled
with 2 mmol/L IR-786 for 30 minutes at room temperature, as described
previously.9
Measurement of MB’s Optical Properties
All measurements were performed in 100% fetal bovine serum (FBS).
Absorbance and fluorescence were measuredwith fiberoptic HR2000 absor-
bance (200–1100 nm) and USB2000FL fluorescence (350-1000 nm)
spectrometers (Ocean Optics, Dunedin, Fla). NIR excitation was provided
by a 5-mW, 654-nm laser diode. Fluorescence quantum yield (QY) of
MB in FBS was calculated by using oxazine 725 in ethylene glycol
(QY¼ 19%)14 as a calibration standard under conditions of matched absor-
bance (absorbance ¼ 0.08) at 654 nm.
Surgical Preparation
All animals were used under the supervision of an approved institutional
protocol. Three hundred–gram Sprague–Dawley rats from Charles River
Laboratories (Wilmington,Mass) were anesthetized with 65mg/kg intraper-
itoneal pentobarbital and were ventilated by means of tracheostomy with an
MRI-1 ventilator (CWE, Inc, Ardmore, Pa). Bilateral thoracotomy and lap-
arotomy were performed, and the lungs, heart, liver, kidney, inferior vena
cava, and skeletal muscles at the abdominal wall were exposed.
Adult female Yorkshire pigs (mean weight, 30 kg) were purchased from
E.M. Parsons and Sons (Hadley, Mass). General anesthesia was induced
with 4.4 mg/kg intramuscular Telazol (Fort Dodge Labs, Fort Dodge,
Iowa). Once sedated, animals were intubated with a cuffed endotracheal
tube, and anesthesiawasmaintainedwith 2% isoflurane/balanceO2. Contin-
uous oxygen saturation, body temperature in the oral cavity, and 3-lead elec-
trocardiographic results were monitored throughout the experiment. After
amedian sternotomywas performed, the heartwas suspended in a pericardial
cradle. Animals received intravenous lidocaine (50 mg) through a left exter-
nal jugular vein catheter before clamping a diagonal branch of the left ante-
rior descending coronary artery (LAD) to prevent ventricular fibrillation.
MB Biodistribution and Clearance
Two milligrams per kilogram of MB was injected intravenously as a bo-
lus over 30 seconds. Under conditions of constant fluence rate and field of
view, 700-nm NIR fluorescence images of the lung, heart, liver, kidney, in-
ferior vena cava, and skeletal muscle at the abdominal wall were acquired
every 500 ms until 1 minute and then at 2 minutes, 5 minutes, and every
5 minutes thereafter for a total of 60 minutes.
Coronary Arteriography and Myocardial Perfusion
Imaging With MB
One milligram per kilogram of MBwas injected intravenously as a bolus
over 30 seconds. Images were acquired every 500 ms until 1 minute and
then at 2 minutes, 5 minutes, and every 5 minutes thereafter for a total of
60 minutes. For some experiments, a diagonal branch of the LAD was
clamped before MB injection. Fifteen minutes after interrupting arterial
flow, the clamp was removed, and ICG (0.06 mg/kg) was injected intrave-
nously. Fifteen minutes after ICG injection, the animal was killed, the heart
was removed, and the cut surface was imaged.
Induction of Intravascular Thrombi in Coronary
Arteries
Up to 2 hours before thrombus induction, 3.6 3 1010 NIR fluorescent
platelets were infused intravenously. A 1 cm 3 1 cm piece of filter paper
was dipped in 50% (wt/wt) aqueous FeCl3 and then placed over a diagonalgery c July 2009
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nm NIR fluorescence within 30 to 45 minutes of FeCl3 application, after
which time 1 mg/kg MB was injected intravenously, as described above.
Quantitation and Statistical Analysis
NIR fluorescence was quantified by using a constant-sized region of in-
terest over reproducible areas of the heart and coronary arteries: midanterior
right ventricular free wall, midanterior left ventricular free wall, bifurcation
of the second diagonal branch, and pericardium. A Mann–Whitney U test
was used for statistical comparison of parameters.
RESULTS
Real-Time, Dual-Channel Intraoperative NIR
Fluorescence Imaging System
A schematic of the imaging system used in this study is
shown in Figure 1. Its 18-inch working distance and articu-
lated arm ensured unobtrusive imaging during cardiac sur-
gery, and its articulated arm permitted precise positioning.
By suppressing motion artifacts, cardiac gating technology
preserved high-resolution imaging of the beating heart (see
below). The color video, 700-nm (NIR fluorescence channel
1), and 800-nm (NIR fluorescence channel 2) images were
acquired simultaneously to display anatomy and function to-
gether, and NIR fluorescence channels were pseudocolored
and overlaid on top of the color video image to create a sep-
arate merged image. All images were refreshed at rates up to
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FIGURE 1. Image-guided surgical system equipped with 2 near-infrared
(NIR) fluorescence channels: schematic of the imaging system showing
light paths for white light, NIR channel 1 excitation (670 nm) and emission
(700 nm), and NIR channel 2 excitation (760 nm) and emission (800 nm).
All images were acquired and displayed simultaneously and in real time.
FIGURE 2. Chemical and optical properties of methylene blue. A, Chem-
ical structure and molecular weight (M.W.; in daltons) of methylthioninium
chloride (methylene blue). B, Absorbance (left axis) and fluorescence (right
axis; 654-nm excitation) for 2 mmol/L methylene blue in 100% FBS.
FIGURE 3. In vivo biodistribution and clearance of methylene blue. A,
Kinetics of 700-nm MB near-infrared (NIR) fluorescence in rat myocar-
dium. Shown are means  standard errors of the mean signal intensity
from 3 independent animals. B, Ratio of NIR fluorescence intensity of the
myocardium relative to various vital organs and tissues after intravenous in-
jection of 2 mg/kg MB in rats (n¼ 3). Shown are values at 0 minutes, at the
time (parentheses) of peak fluorescence in the organ/tissue under study, and
at 60 minutes. IVC, Inferior vena cava.The Journal of Thoracic and Cardiovascular Surgery c Volume 138, Number 1 135
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Evolving Technology/Basic Science Tanaka et alFIGURE 4. Real-time simultaneous assessment of myocardial perfusion and coronary angiography using methylene blue (MB) and indocyanine green
(ICG). A, The arterial phase (12 seconds), venous phase (1 minute), and late phase (10 minutes) after intravenous bolus injection of 1 mg/kg MB into
pigs are shown. A diagonal branch of the left anterior descending coronary artery (LAD) was clamped immediately before MB injection, with the perfusion
defect easily detected (arrows). Shown are color video (top row), near-infrared (NIR) fluorescence (middle row), and a pseudocolored (lime green) merge of
the two (bottom row). NIR fluorescence images were acquired with a 100-ms exposure time and are displayed with identical normalizations. Images are rep-
resentative of 5 independent animals. B, The arterial phase (12 seconds), venous phase (1minute), and late phase (10minutes) after declamping of the diagonal
branch and intravenous bolus injection of 0.06 mg/kg ICG into the pig from panel A are shown.Arrowsmark the location of the previous perfusion defect seen
with MB. Shown are color video (top row), NIR fluorescence (middle row), and a pseudocolored (lime green) merge of the two (bottom row). NIR fluores-
cence images were acquired with a 100-ms exposure time and are displayed with identical normalizations. Images are representative of 5 independent animals.136 The Journal of Thoracic and Cardiovascular Surgery c July 2009
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light are invisible to the human eye, the surgical field appears
completely normal.
Chemical and Optical Properties of MB
MB (methylthioninium chloride) is a lipophilic, cationic
(charge¼þ1), 321-d small molecule with a distributed elec-
tron resonance (Figure 2, A). In 100% serum, peak absor-
bance and emission were found to be 667 nm and 686 nm,
respectively (Figure 2, B). Its extinction coefficient at 667
nm (e667nm) was found to be 46,000 M1cm1. QY in
100% serum was 2.5%. The product of e667nm and QY in-
dicated low-to-moderate total fluorescence compared with
that seen with other NIR fluorophores, such as ICG (ePeak
absorbance ¼ 166,000 M1cm1 and QY ¼ 9% in serum).5
In Vivo Biodistribution and Clearance
MB displays no protein binding after intravenous injec-
tion.15 After intravenous bolus injection of 2 mg/kg into
a rat, region-of-interest analysis over the myocardium re-
vealed high uptake of MB, peaking at 28 seconds, and slow
washout, with the NIR fluorescence signal returning to back-
ground levels by 40 to 60 minutes (Figure 3, A). Other vital
organs and tissues also exhibited uptake of MB, with peak
fluorescence occurring between 15 and 57 seconds after injec-
tion (Figure 3,B). TheNIRfluorescence signal fromall except
the kidney returned to baseline by 60 minutes. Excretion of
MB was found to be both renal and hepatic (data not shown).
Coronary Arteriography and Myocardial Perfusion
Imaging With MB
In a human-sized pig, 700-nm MB fluorescence provided
sensitive coronary arteriography, with the arterial phase
peaking 12 seconds after intravenous bolus injection (Fig-
ure 4, A). Unlike blood pool agents, such as ICG, and like
other lipophilic cations,16 MB was extracted completely
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FIGURE 4. (Continued). C, Quantitative analysis of the ratio of myocar-
dial NIR fluorescence to coronary artery NIR fluorescence 10 minutes after
intravenous bolus injection of either ICG or MB is shown. Shown are the
means  standard errors of the mean of 5 independent animals, along
with the statistical comparison of the 2 NIR fluorophores at each time point.The Journal of Thoracic and Cby the myocardium. This eliminates the venous phase but
also provides direct visualization of the myocardial perfu-
sion or arterial runoff (Figure 4, A). As seen in the rat,
peak NIR fluorescence in the myocardium occurred at 1
minute after MB injection, persisted for more than 10 min-
utes (Figure 4, A), and returned to baseline value by 40 to
60 minutes. Importantly, MB NIR fluorescence contrast
was so high that myocardium with an induced perfusion de-
fect could be detected with high sensitivity (Figure 4, A).
The perfusion defect was reversed, and 0.06 mg/kg ICG
was injected intravenously as a bolus. By using the dual-
channel capability of the imaging system, the opened artery
could be assessed in real time, with peak fluorescence occur-
ring at 12 seconds after injection (Figure 4, B). Because ICG
uptake into the myocardium is negligible, venous filling can
be assessed (Figure 4, B) but not perfusion. Quantitative
comparison of the ratio between myocardial fluorescence
and coronary artery fluorescence at various time points after
intravenous injection of ICG and MB is shown in Figure 4,
C, and confirms the qualitative results. Taken together, MB
and ICG, in conjunction with the dual-channel imaging
system, permitted simultaneous, real-time, quantitative as-
sessment of arterial filling, venous filling, and myocardial
perfusion during cardiac surgery in the beating heart.
Simultaneous Detection of Coronary Arterial Flow,
Myocardial Perfusion, and Acute Thrombi
Presently, there is no method available for the sensitive
detection of intravascular thrombi during cardiac surgery.
We have previously demonstrated that intravenously in-
jected 800-nm NIR fluorescent platelets will home to the
sites of intravascular thrombi to provide high-sensitivity de-
tection.9 The present study demonstrates that the combina-
tion of 800-nm NIR fluorescent platelets and 700-nm MB,
in conjunction with the dual-channel imaging system, can
be used to detect thrombi forming in even small branches
of the coronary arteries and, importantly, can provide func-
tional information about vessel patency. The diagonal
branch of the LAD harboring a thrombus is completely oc-
cluded, as assessed with MB (Figure 5). Indeed, the throm-
bus shown in Figure 5 is the smallest seen in 4 animals,
measuring submillimeters in size, which highlights the sen-
sitivity of the technology and the motion-suppressing, high-
resolution capabilities of the imaging system.
DISCUSSION
In CABG there is still no widely accepted or broadly used
intraoperative technique to assess the quality of the anasto-
mosis or the bypass graft itself. The clinical consequences
of early graft failure are devastating. In a recent report the
30-day mortality among patients with early postoperative
graft failure was more than 9%.17 Because graft patency is
the predominant factor in long-term survival and avoidance
of reintervention after CABG surgery, an intraoperativeardiovascular Surgery c Volume 138, Number 1 137
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Evolving Technology/Basic Science Tanaka et alFIGURE 5. Real-time simultaneous assessment of acute coronary artery thrombi and coronary artery patency. A coronary artery thrombus was induced in
a diagonal branch of the left anterior descending coronary artery (LAD) by means of treatment with FeCl3 (center of dotted rectangle). Thrombus size and
location were quantified by means of intravenous injection of IR-786–labeled autologous platelets (800-nm fluorescence; pseudocolored in magenta in the
merged image). Coronary artery patency (and tissue perfusion) was quantified by means of intravenous bolus injection of 1 mg/kg MB (700-nm fluorescence;
pseudocolored in lime green in merged image). Shown are color video (first column), 800-nm NIR fluorescence (second column), 700-nm NIR fluorescence
(third column), and a pseudocoloredmerge of the three (fourth column) at 12 seconds after MB injection. The area within the dotted rectangle in the top row is
shown magnified 4-fold in the bottom row. NIR fluorescence images were acquired with a 100-ms exposure time and are displayed with identical normal-
izations. Images are representative of 4 independent animals.means of assessing revascularization would be extremely
helpful. This need to assess intraoperative patency and myo-
cardial perfusion has been emphasized in recent studies that
demonstrate significant surgeon-dependent variations in
graft patency in off-pump CABG procedures.18
Among graft assessment techniques currently available,
iodine-based coronary angiography remains the gold stan-
dard for postoperative assessment. However, catheterization
and fluoroscopy equipment is typically not available in the
operating room. Although the assessment of graft patency
by using thermal angiography,19 an electromagnetic flowme-
ter,20 or Doppler flow measurement,21 have been attempted
clinically, such techniques generally do not provide images
and have not been routinely implemented in the field of
surgery thus far.22 Transit-time ultrasonic flowmeasurement
has also become a popular method to assess graft pa-
tency.23,24 Although transit-time ultrasonic flow measure-
ment is rapid and simple to use, the technique does not
produce an image, and interpretation of flow data is often
difficult and less intuitive than an angiographic presentation
of the graft status.
ICG angiography is a promising new technique for intra-
operative assessment during CABG surgery.11,12 Recent
publications demonstrate that ICG angiography might be
an effective and reproducible method for the evaluation of
graft status.10 In this study we describe a dual-channel
NIR fluorescence imaging system capable of visualizing
800-nm ICG fluorescence simultaneously with 700-nm138 The Journal of Thoracic and Cardiovascular SurMB fluorescence. We also demonstrate that MB, already
FDA-approved for intravenous use in the treatment of met-
hemoglobinemia at a dose of 1 to 2 mg/kg, has unusually
high uptake into the myocardium and thus serves as a simple,
yet powerful visual tracer of myocardial perfusion and arte-
rial runoff. ICG is a true blood pool agent; that is, it flows
into arteries and then out of veins, providing approximately
3 to 4 seconds of imaging in each structure as it passes
through. Although ICG can be used as a surrogate for car-
diac perfusion,25 quantitation is difficult, and perfusion is
never actually visualized. MB, on the other hand, provides
imaging of arteries but is then efficiently extracted into the
myocardium during its first pass through the capillaries. Im-
portantly, because there is no spectral overlap between ICG
and MB, our dual-channel imaging system permits the com-
plementary information from both to be imaged simulta-
neously.
However, MB does have limitations for clinical use. A
factitious and transient decrease in pulse oximetry readings
is always observed after its intravenous injection.26 MB’s
extinction coefficient and QY in serum are relatively low,
and serious adverse reactions have been reported when
used at doses of 7.5 mg/kg.27 Even at 1 mg/kg, it is usually
administered as a slow bolus over 15 minutes rather than the
15-second administration used in this study. Although no
acute toxicity was seen in either rats or pigs, this is an impor-
tant consideration for translation to patients. Of course, ab-
solute fluorescence intensity is the product of the 670-nmgery c July 2009
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cardium, and camera exposure time. In experiments not
shown, the dose could be reduced 2-fold when either the flu-
ence rate or exposure time was doubled and 4-fold when
both were doubled. Because there is a tradeoff between ex-
posure time and resolution as a result of cardiac motion, we
expect that the fluence rate will be the key to decreasing the
MB dose, with a maximum likely being 10 mW/cm2 (4-fold
higher than used in this study, leading to a 4-fold lower MB
dose) because of changes in FDA-regulated color balance
that occur with higher fluence rate. Finally, opaque and
semiopaque structures overlying vessels and the myocar-
dium can lead to false-positive filling defects, making the
Color-NIR Merge images of paramount importance for in-
terpreting results.
The dual-channel capability of the imaging system would
be particularly useful with acute intravascular thrombi.
Thrombus formation is a key event in the pathogenesis of
acute occlusion of the coronary arteries,28 yet there is pres-
ently no method for its sensitive detection. The 700-nm
MB NIR fluorescence did not interfere with the 800-nm
NIR fluorescence from platelets, permitting real-time and
simultaneous assessment of thrombus size, arterial patency,
and myocardial perfusion and thus the opportunity for intra-
operative intervention. One can envision that with the devel-
opment of additional targeted 800-nm fluorophores, such as
those specific for cardiac stem cells, fibrosis, or other impor-
tant features, cardiac surgeons could use the 800-nm channel
to tailor image guidance during cardiac surgery.
One major limitation of the simple reflectance imaging
system used in this study is depth penetration and surface
weighting of fluorescence intensity. Although it can detect
fluorescent lymph nodes through up to 1 cm of solid tissue29
and 5 cm of lung tissue30 against a low autofluorescent
background, it is unlikely that our imaging system will be
able to detect subendocardial or septal ischemia in the ab-
sence of epicardial ischemia. Recent advances in optical
tomography suggest that depth penetration up to 2 cm might
someday be possible, although no study to date has attemp-
ted to apply tomography to moving objects, such as the
heart.
Finally, the decay of MB NIR fluorescence from the myo-
cardium is a complex function of physiologic, chemical, and
optical variables. MB is sensitive to the redox state and in the
presence of a reducing agent is converted to the colorless,
nonfluorescent chemical leucomethylene blue. Leucomethy-
lene blue is also uncharged, which permits diffusion out of
myocytes and clearance from the body. Thus an added fea-
ture of MB imaging of the heart might be a direct visual
assessment of the redox state, with a highly reducing envi-
ronment leading to lower peak fluorescence and a more rapid
return to baseline values and a highly oxidizing environment
leading to high peak fluorescence and a slower return to
baseline. Studies exploring whether these simple quantita-The Journal of Thoracic and Ctive measurements might provide the cardiac surgeon with
additional information about the oxidative (ie, ischemic)
state of the heart are ongoing.
In summary, MB as a 700-nm NIR fluorophore for visual-
ization of coronary arteriography and myocardial perfusion,
independent 800-nm NIR fluorophores for visualization of
other physiologic processes, and a dual-channel intraopera-
tive NIR fluorescence imaging system provide unprece-
dented image guidance during cardiac surgery.
We thank Barbara L. Clough and Alice Gugelmann for editing
and Eugenia Trabucchi for administrative assistance.
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